Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of placental weight at birth with maternal whole blood concentration of heavy metals (cadmium, lead, mercury, selenium, and manganese): The Japan Environment and Children's Study (JECS).
Kinjo Y, Shibata E, Askew DJ, Tanaka R, Suga R, Shimono M, Sakuragi T, Morokuma S, Ogawa M, Sanefuji M, Hamada N, Ochiai M, Ohga S, Tsuji M, Kusuhara K, Yoshino K; Japan Environment and Children's Study Group. Kinjo Y, et al. Environ Int. 2024 May 13;188:108725. doi: 10.1016/j.envint.2024.108725. Online ahead of print. Environ Int. 2024. PMID: 38759546 Free article.
Endovascular treatment of acute atherothrombotic internal carotid artery occlusion associated with persistent primitive hypoglossal artery.
Ishizuka T, Endo H, Yamaguchi S, Hiratsuka Y, Noro S, Ishikawa K, Fuchizaki T, Tatsuta Y, Sakurai S, Shindo K, Yamaguchi Y, Ogino T, Kamiyama K, Osato T, Nakamura H. Ishizuka T, et al. Clin Neurol Neurosurg. 2024 Mar;238:108179. doi: 10.1016/j.clineuro.2024.108179. Epub 2024 Feb 16. Clin Neurol Neurosurg. 2024. PMID: 38387238
Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma: a pooled analysis of two phase I studies.
Takahashi S, Bando H, Kinoshita I, Modi S, Tsurutani J, Bang YJ, Sato Y, Nakatani S, Lee C, Sugihara M, Okuda Y, Iwata H. Takahashi S, et al. Jpn J Clin Oncol. 2024 Apr 6;54(4):434-443. doi: 10.1093/jjco/hyad181. Jpn J Clin Oncol. 2024. PMID: 38231777 Free PMC article.
BACKGROUND: HER2-expressing salivary gland carcinoma (SGC) is associated with poor prognosis. Trastuzumab deruxtecan (T-DXd, DS-8201) has shown evidence of antitumor activity for several HER2-expressing solid tumors in multiple studies. This study aimed to present the effi …
BACKGROUND: HER2-expressing salivary gland carcinoma (SGC) is associated with poor prognosis. Trastuzumab deruxtecan (T-DXd, DS-8201) …
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo S, Miyazaki Y, Todoroki Y, Nagayasu A, Kanda R, Aritomi T, Matsunaga S, Ueno M, Miyagawa I, Sonomoto K, Hanami K, Nakayamada S, Tanaka Y. Kubo S, et al. Rheumatol Ther. 2023 Dec;10(6):1705-1723. doi: 10.1007/s40744-023-00603-8. Epub 2023 Oct 19. Rheumatol Ther. 2023. PMID: 37856034 Free PMC article.
In contrast, JAK inhibitors were less frequently used in patients aged 75 years and older (7.8%), with cytotoxic T lymphocyte antigen 4 immunoglobulin fusion proteins (CTLA4-Ig) being the most common (39.2%). ...
In contrast, JAK inhibitors were less frequently used in patients aged 75 years and older (7.8%), with cytotoxic T lymphocyte antigen …
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
Baba T, Kusumoto M, Kato T, Kurihara Y, Sasaki S, Oikado K, Saito Y, Endo M, Fujiwara Y, Kenmotsu H, Sata M, Takano T, Kato K, Hirata K, Katagiri T, Saito H, Kuwano K. Baba T, et al. Int J Clin Oncol. 2023 Dec;28(12):1585-1596. doi: 10.1007/s10147-023-02414-x. Epub 2023 Oct 3. Int J Clin Oncol. 2023. PMID: 37787866 Free PMC article.
BACKGROUND: Interstitial lung disease/pneumonitis (ILD/pneumonitis) has been identified as a drug-related adverse event of special interest of trastuzumab deruxtecan (T-DXd), but there were a few reports of T-DXd-related ILD/pneumonitis in clinical practice. ...RESU …
BACKGROUND: Interstitial lung disease/pneumonitis (ILD/pneumonitis) has been identified as a drug-related adverse event of special interest …
75 results